Target intelligence / Profile preview

RNY3 pseudogene 2 (RNY3P2)

Target
RNY3P2
Molecular classification
Other (Pseudogene; Non-coding RNA pseudogene)
01

Overview

**RNY3 pseudogene 2 (RNY3P2)** is a human pseudogene related to the RNY3 (Ro-associated Y3 RNA) gene, which encodes a small non-coding Y-RNA; as a pseudogene, RNY3P2 is a non-functional genetic element formed through mutation or duplication and does not produce a functional protein or known regulatory RNA. Pseudogenes in general can sometimes regulate their cognate genes post-transcriptionally (e.g., via antisense transcripts, miRNA competition, or RNA-binding protein interactions), but there is no evidence in current sources that RNY3P2 has any known biological function, therapeutic relevance, or clinical impact[2][6]. The parental RNY3 gene is involved in DNA replication and RNA quality control and has been studied in immune response and DNA replication contexts[1][5]. Over 1,000 Y-RNA pseudogenes exist in the human genome, and most do not have known functions[5]. No drugs, mechanisms of action, biomarker roles, or specific disease links are assigned to RNY3P2, and there is no evidence it is a relevant therapeutic or biological target.\n\n**Key notes on accuracy and nomenclature:**\n- There is no evidence that RNY3P2 is a functional molecule, a therapeutic target, a receptor, enzyme, or bona fide biological regulator[1][2][5]; it is a non-functional pseudogene.\n- Reason for **is_incorrect: true** — the request treats RNY3P2 as a discrete, meaningful therapeutic target, but available data show it is a non-functional pseudogene and not a receptor, enzyme, or recognized drug target[2][6]. If you intended to ask about "RNY3" or a different functional target, please clarify.

Other names
RNA, Ro-associated Y3 pseudogene 2RNY3P2RNA, Ro60-associated Y3 pseudogene 2
02

Biological functions

Other (no established biological function for this specific pseudogene; possible regulatory RNA roles by analogy with other pseudogenes)
03

Disease associations

Other (no directly described disease associations or clinical relevance for RNY3P2)

Beyond the preview

Go deeper on RNY3 pseudogene 2 (RNY3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNY3 pseudogene 2 (RNY3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call